LUNGevity is committed to providing accurate, up-to-date information on the COVID-19 pandemic and how it affects people with lung cancer as soon as it becomes available. We are working closely with our Scientific Advisory Board, composed of experts in the lung cancer field, and other lung cancer-focused nonprofits to provide information specific to people affected by lung cancer.
LUNGevity has also been active in working to shape public policy in this unprecedented situation. In conjunction with other disease-focused nonprofits, we have signed on to several letter to Congress and state officials laying out the unique needs of our at-risk patient population and asking for solutions. View the letters in the COVID-19 section of our Comment & Sign-On Letters page.
Our content continues to evolve; please check back often for updates.